江南化工(002226) - 2019 Q3 - 季度财报

Financial Performance - Net profit attributable to shareholders increased by 55.06% to CNY 164,311,908.04 for the reporting period[9]. - Operating revenue for the reporting period reached CNY 969,114,357.32, reflecting a growth of 21.21% year-on-year[9]. - Basic earnings per share rose by 55.19% to CNY 0.1316 for the reporting period[9]. - Total profit for the reporting period was CNY 525,806,788.38, an increase of 76.95% compared to the same period last year[23]. - The total comprehensive income for the period attributable to the parent company's owners was CNY 362,359,446.14, an increase from CNY 128,281,551.02 in the previous period[119]. - The company reported a net profit of CNY 45,258,359.74, significantly higher than CNY 12,586,828.80 in the previous period, marking an increase of approximately 259.5%[123]. Assets and Liabilities - Total assets increased by 1.14% to CNY 12,178,812,231.92 compared to the end of the previous year[9]. - The company's trading financial assets at the end of the reporting period amounted to CNY 190,560,000, an increase of 100% compared to the beginning of the year[20]. - Total current assets increased to ¥3,656,538,573.15 from ¥3,468,251,795.04, representing a growth of approximately 5.45%[78]. - Total non-current assets decreased slightly to ¥8,522,273,658.77 from ¥8,572,936,808.36, a decline of about 0.59%[78]. - Total liabilities decreased to ¥5,497,016,272.37 from ¥5,807,610,618.36, reflecting a decrease of about 5.34%[81]. - Long-term borrowings decreased to ¥3,239,000,000.00 from ¥3,483,980,000.00, a decline of approximately 7.03%[81]. Cash Flow - The net cash flow from operating activities decreased by 14.68% to CNY 262,748,679.45 compared to the same period last year[9]. - The net cash flow generated from operating activities was CNY 520,039,330.84, compared to CNY 438,526,806.99 in the previous period, showing an increase of about 18.6%[131]. - The net cash flow from investing activities was -763,164,849.97, worsening from -465,592,481.27 in the previous period, highlighting increased investment expenditures[139]. - Total cash inflow from financing activities was 833,336,813.53, down from 850,870,691.81, indicating reduced financing activities[139]. Shareholder Information - The total number of shareholders at the end of the reporting period was 63,766[13]. - The largest shareholder, Shun'an Holding Group Co., Ltd., holds 36.82% of the shares[13]. Government and Other Income - The company received government subsidies amounting to CNY 11,063,167.89 during the reporting period[9]. - Investment income for the reporting period was CNY 33,767,916.62, an increase of 276.40% year-on-year[20]. - The company reported a fair value change gain of 13,715,600.00 RMB on financial assets during the reporting period[67]. Commitments and Governance - The company commits to avoiding competition with Jiangnan Chemical and will not establish any new businesses that may compete directly or indirectly within China[36]. - The company guarantees that all related transactions will be conducted based on fair market principles and will undergo necessary review procedures to protect the interests of Jiangnan Chemical and its minority shareholders[39]. - The company has established a commitment to ensure the independence of Jiangnan Chemical's governance structure and operations, including maintaining independent financial and operational management[49]. Research and Development - Research and development expenses for the current period were ¥13,995,141.14, slightly up from ¥13,034,289.65 in the previous period[95]. - Research and development expenses rose to CNY 9,634,316.00 from CNY 7,828,668.76, indicating an increase of approximately 23.1%[123]. Inventory and Receivables - Accounts receivable increased to 1,497,932,859.41 RMB from 1,160,061,200.60 RMB in 2018, indicating a significant rise in credit sales[75]. - Inventory levels rose to 179,096,544.96 RMB compared to 137,986,595.69 RMB in the previous year, reflecting increased production or stockpiling[75].